• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.

作者信息

Bentzen S M, Ruifrok A C, Thames H D

机构信息

Department of Biomathematics, University of Texas, M.D. Anderson Cancer Center, Houston, USA.

出版信息

Radiother Oncol. 1996 Feb;38(2):89-101. doi: 10.1016/0167-8140(95)01689-9.

DOI:10.1016/0167-8140(95)01689-9
PMID:8966232
Abstract

Early mucosal reactions are a major concern in radiotherapy of tumors in the head and neck. With some of the current strategies for altered fractionation these reactions may become dose limiting, and this has created a renewed interest in their radiobiology. The present paper reviews data on the response of mucosa in the head and neck to a change in dose per fraction (repair capacity) and time interval between dose fractions (repair kinetics). A review of clinical data on repair capacity shows that the alpha/beta ratio of the linear-quadratic model is high, around 10 Gy. Also, the steepness of the dose-response curve for mucositis is high as quantified by the maximum value of the normalized dose-response gradient, gamma 50 = 6.9 +/- 2.1. Computer simulations illustrate how this high value may be explained by the structural and proliferative organization of the mucosa. Finally, data from the following four recent studies are analyzed: the Radiation Therapy Oncology Group studies 7913 and 8313, a study from the M.D. Anderson Cancer Center, and a study from the Center of Oncology in Warsaw. All of these studies showed a decrease in the incidence of mucosal reactions when the interval between fractions given in the same day was increased, typically from around 4 h to around 6 h. It is shown that the maximum dose-equivalent of repair in the time interval between 4 h and 6 h occurs for a repair halftime of about 3.2 h. A comparison between the steepness of dose-response curves from studies not involving incomplete repair and those derived from the above four studies shows that the repair halftime for human mucosa must be relatively long, probably in the range 2 to 4 h. The statistical resolution of the available data as well as a number of caveats in the design of the studies preclude a more rigorous estimation of the repair halftime for mucosa. Although the tumor data are less conclusive, a similar repair halftime cannot be excluded for epithelial tumors in the head and neck.

摘要

相似文献

1
Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.
Radiother Oncol. 1996 Feb;38(2):89-101. doi: 10.1016/0167-8140(95)01689-9.
2
Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.根据对头颈部癌患者进行加速超分割放疗(CHART)或传统放疗后与治疗相关的发病率观察结果估算的修复半衰期。
Radiother Oncol. 1999 Dec;53(3):219-26. doi: 10.1016/s0167-8140(99)00151-6.
3
Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.头颈部癌放疗相关早期并发症:从CHART试验推导的定量临床放射生物学
Radiother Oncol. 2001 Aug;60(2):123-35. doi: 10.1016/s0167-8140(01)00358-9.
4
Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa.
Int J Radiat Oncol Biol Phys. 1990 Aug;19(2):301-11. doi: 10.1016/0360-3016(90)90538-u.
5
Linear quadratic model--estimation of alpha/beta ratio for mucosal reaction.
Strahlenther Onkol. 1993 Jul;169(7):427-30.
6
Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.粒细胞巨噬细胞集落刺激因子(GM-CSF)对头颈部癌患者放射性口腔黏膜炎的发生频率和严重程度的疗效及安全性
Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1005-10. doi: 10.1016/s0360-3016(97)00105-3.
7
Radiation treatment breaks and ulcerative mucositis in head and neck cancer.头颈部癌的放射治疗损伤与溃疡性黏膜炎
Oncologist. 2008 Aug;13(8):886-98. doi: 10.1634/theoncologist.2008-0024. Epub 2008 Aug 13.
8
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy.对放疗中使用不同方法补偿错过治疗天数的效果进行的模型比较。
Clin Oncol (R Coll Radiol). 1996;8(5):297-307. doi: 10.1016/s0936-6555(05)80715-0.
9
Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.接受根治性放疗的头颈癌患者正常组织反应与局部肿瘤控制的比较。
Int J Radiat Oncol Biol Phys. 1996 Jun 1;35(3):455-62. doi: 10.1016/s0360-3016(96)80006-x.
10
Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.同步整合加量调强放射治疗局部晚期头颈部鳞状细胞癌:II期临床结果
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87. doi: 10.1016/j.ijrobp.2004.03.010.

引用本文的文献

1
Comparison of dose calculation approaches and clinical dose-response in image-guided head&neck brachytherapy of the oral cavity.口腔图像引导头颈部近距离放射治疗中剂量计算方法与临床剂量反应的比较
Clin Transl Radiat Oncol. 2025 May 8;53:100968. doi: 10.1016/j.ctro.2025.100968. eCollection 2025 Jul.
2
Classification of tolerable/intolerable mucosal toxicity of head-and-neck radiotherapy schedules with a biomathematical model of cell dynamics.利用细胞动力学的生物数学模型对头颈部放疗方案的可耐受/不可耐受黏膜毒性进行分类。
Med Phys. 2021 Jul;48(7):4075-4084. doi: 10.1002/mp.14834. Epub 2021 Jul 9.
3
[Concurrent once-daily or twice-daily chemoradiotherapy in limited-stage small-cell lung cancer?].
[局限期小细胞肺癌每日一次或每日两次同步放化疗?]
Strahlenther Onkol. 2018 Jan;194(1):73-75. doi: 10.1007/s00066-017-1234-6.
4
[Arrhythmias].[心律失常]
Med Klin Intensivmed Notfmed. 2014 Nov;109(8):564-5.
5
[Risks of unfavorable cosmetic and toxicity after percutaneous accelerated partial breast irradiation (APBI). Interim analysis from the Canadian RAPID trial].[经皮加速部分乳腺照射(APBI)后出现不良美容效果和毒性的风险。加拿大RAPID试验的中期分析]
Strahlenther Onkol. 2013 Dec;189(12):1054-5. doi: 10.1007/s00066-013-0447-6.
6
Biphasic and monophasic repair: comparative implications for biologically equivalent dose calculations in pulsed dose rate brachytherapy of cervical carcinoma.双相和单相修复:在宫颈癌脉冲剂量率近距离放射治疗中,对生物学等效剂量计算的比较影响。
Br J Radiol. 2013 Sep;86(1029):20130288. doi: 10.1259/bjr.20130288. Epub 2013 Aug 9.
7
Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.弥散加权成像预测诱导化疗治疗头颈部鳞状细胞癌患者无进展生存期。
Acad Radiol. 2011 Oct;18(10):1225-32. doi: 10.1016/j.acra.2011.06.009. Epub 2011 Aug 10.
8
Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution.直接瘤内输注脂质体包裹的锝放射性核素治疗癌症:非均匀瘤内剂量分布的影响。
Med Phys. 2011 Mar;38(3):1339-47. doi: 10.1118/1.3552923.
9
Reports of unexpected late side effects of accelerated partial breast irradiation--radiobiological considerations.加速部分乳腺照射意外晚期副作用的报告——放射生物学考量
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):969-73. doi: 10.1016/j.ijrobp.2010.01.059.
10
A new view of radiation-induced cancer: integrating short- and long-term processes. Part II: second cancer risk estimation.辐射诱发癌症的新观点:整合短期和长期过程。第二部分:二次癌症风险评估。
Radiat Environ Biophys. 2009 Aug;48(3):275-86. doi: 10.1007/s00411-009-0231-2. Epub 2009 Jun 5.